Skip to content

Clinical trials

Terminated Pancreatic Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Status: Terminated Country / region: Germany Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20074
20094
20101
20111
20121
20142
20151
20161
20171
20203
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Amgen1
Auron Healthcare GmbH1
CHIR-Net1
Celgene1
German Cancer Research Center1
Heidelberg University1
Incyte Corporation1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1
Ludwig-Maximilians - University of Munich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms23
Adenocarcinoma3
Colorectal Neoplasms3
Stomach Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Cholestasis2
Esophageal Neoplasms2
Gallbladder Neoplasms2
Liver Neoplasms2
Melanoma2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.